Tumor Tissue Shared Resource

The Tumor Tissue Shared Resource supports research studies evaluating tumor biology and its implications for treatment. The Tumor Tissue Shared Resource is comprised of the:

  • Tumor Bank
    The Tumor Bank stores fresh tissue excised in the course of standard operations to remove tumors. Samples are derived from remnant tissues not necessary for diagnostic or treatment related purposes. In addition, leukemia and bone marrow samples are also collected.
  • Advanced Tumor Bank
    The Advanced Tumor Bank functions in the same way as the Tumor Bank except that additional information related to the samples is available to researchers. All Advanced Tumor Bank participants have consented to donate tissue, blood and/or body fluids, and have signed a HIPAA waiver to release demographic information.

These samples are important because they allow our faculty the ability to answer vital, basic and population science research questions related to risk factors and outcomes.  In addition to the two tissue banks, the Tumor Tissue Facility strictly monitors quality control so that tissues are consistent and reliable for research.

To Request Tissue Samples

To apply for tissue from the Tumor Bank contact Dr. Greg Kucera via e-mail (gkucera@wakehealth.edu).

Published Research

  • Suganuma N, Segade F, Matsuzu K, Bowden DW. Differential expression of facilitative glucose transporters in normal and tumor kidney tissues. BJU Int. 2007 May;99(5):1143-9.
  • Matsuzu K, Segade F, Wong M, Clark OH, Perrier ND, Bowden DW.
  • Glucose transporters in the thyroid. Thyroid. 2005 Jun;15(6):545-50.  
  • Blish KR, Clausen KA, Hawkins GA, Garvin AJ, Willingham MC, Turner JC, Torti FM, Torti SV. Loss of heterozygosity and SOSTDC1 in adult and pediatric renal tumors. J Exp Clin Cancer Res. 2010 Nov 16;29(1):147.
  • Xu J, Kibel AS, Hu JJ, Turner AR, Pruett K, Zheng SL, Sun J, Isaacs SD, Wiley KE, Kim ST, Hsu FC, Wu W, Torti FM, Walsh PC, Chang BL, Isaacs WB. Prostate cancer risk associated loci in African Americans. Cancer Epidemiol Biomarkers Prev. 2009 Jul;18(7):2145-9.
  • Blish KR, Wang W, Willingham MC, Du W, Birse CE, Krishnan SR, Brown JC, Hawkins GA, Garvin AJ, D'Agostino RB Jr, Torti FM, Torti SV. A human bone morphogenetic protein antagonist is down-regulated in renal cancer. Mol Biol Cell. 2008 Feb;19(2):457-64.

Contact Us 

Dr. Greg Kucera
gkucera@wakehealth.edu

Last Updated: 03-18-2014
USNWR 2013-2014Magnet Hospital RecognitionConsumer Choice2014 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.